The performance of matrices in daily clinical practice to predict rapid radiologic progression in patients with early RA

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 5, 2014, Pages 627-631

  De Cock, D ^a   Vanderschueren, G ^b   Meyfroidt, S ^a   Joly, J ^b   Van der Elst, K ^a,b   Westhovens, R ^a,b   Verschueren, P ^a,b  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Daily clinical practice; Early rheumatoid arthritis; Prediction models; Rapid radiologic progression

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR; STEROID;

ADULT; ARTICLE; ASPIRE CRP MATRIX; ASPIRE ESR MATRIX; BEST MATRIX; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; ESPOIR MATRIX; FACE VALIDITY; FEMALE; FOOT RADIOGRAPHY; GENDER; HAND RADIOGRAPHY; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RHEUMATOID ARTHRITIS; SMOKING; STATISTICAL PARAMETERS; SWEFOT MATRIX; AGED; FOOT; HAND JOINT; RADIOGRAPHY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FOOT JOINTS; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84898787351     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.09.004     Document Type: Article

References (34)

1. Landewe R.B., Boers M., Verhoeven A.C., Westhovens R., van de Laar M.A., Markusse H.M., et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002, 46:347-356. [Epub 2002/02/13].
2. Jones G., Halbert J., Crotty M., Shanahan E.M., Batterham M., Ahern M. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. Rheumatology (Oxford) 2003, 42:6-13. [Epub 2003/01/02].
3. Korpela M., Laasonen L., Hannonen P., Kautiainen H., Leirisalo-Repo M., Hakala M., et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004, 50:2072-2081. [Epub 2004/07/13].
4. Finckh A., Liang M.H., van Herckenrode C.M., de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006, 55:864-872. [Epub 2006/12/02].
5. Kyburz D., Gabay C., Michel B.A., Finckh A. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford) 2011, 50:1106-1110. [Epub 2011/01/25].
6. Combe B., Dougados M., Goupille P., Cantagrel A., Eliaou J.F., Sibilia J., et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum 2001, 44:1736-1743. [Epub 2001/08/18].
7. Drossaers-Bakker K.W., Zwinderman A.H., Vliet Vlieland T.P., Van Zeben D., Vos K., Breedveld F.C., et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 2002, 47:383-390. [Epub 2002/09/05].
8. Breedveld F.C., Emery P., Keystone E., Patel K., Furst D.E., Kalden J.R., et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004, 63:149-155. [Epub 2004/01/15].
9. Smolen J.S., Han C., Bala M., Maini R.N., Kalden J.R., van der Heijde D., et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005, 52:1020-1030. [Epub 2005/04/09].
10. Lindqvist E., Eberhardt K., Bendtzen K., Heinegard D., Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005, 64:196-201. [Epub 2004/10/02].
11. Landewe R., van der Heijde D., Klareskog L., van Vollenhoven R., Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006, 54:3119-3125. [Epub 2006/09/30].
12. Smolen J.S., Van Der Heijde D.M., St Clair E.W., Emery P., Bathon J.M., Keystone E., et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 2006, 54:702-710. [Epub 2006/03/02].
13. Berglin E., Johansson T., Sundin U., Jidell E., Wadell G., Hallmans G., et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006, 65:453-458. [Epub 2005/09/24].
14. Machold K.P., Stamm T.A., Nell V.P., Pflugbeil S., Aletaha D., Steiner G., et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford) 2007, 46:342-349. [Epub 2006/08/11].
15. Courvoisier N., Dougados M., Cantagrel A., Goupille P., Meyer O., Sibilia J., et al. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study. Arthritis Res Ther 2008, 10:R106. [Epub 2008/09/06].
16. Mouterde G., Lukas C., Logeart I., Flipo R.M., Rincheval N., Daures J.P., et al. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis 2011, 70:1251-1256. [Epub 2011/04/26].
17. Nyhall-Wahlin B.M., Turesson C., Jacobsson L.T., Nilsson J.A., Forslind K., Albertsson K., et al. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years. Scand J Rheumatol 2011, 40:81-87. [Epub 2010/10/06].
18. Klein-Wieringa I.R., van der Linden M.P., Knevel R., Kwekkeboom J.C., van Beelen E., Huizinga T.W., et al. Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis Rheum 2011, 63:2567-2574. [Epub 2011/05/14].
19. Houseman M., Potter C., Marshall N., Lakey R., Cawston T., Griffiths I., et al. Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up. Arthritis Res Ther 2012, 14:R30. [Epub 2012/02/09].
20. Vastesaeger N., Xu S., Aletaha D., St Clair E.W., Smolen J.S. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology (Oxford) 2009, 48:1114-1121. [Epub 2009/07/11].
21. Visser K., Goekoop-Ruiterman Y.P., de Vries-Bouwstra J.K., Ronday H.K., Seys P.E., Kerstens P.J., et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis 2010, 69:1333-1337. [Epub 2010/05/26].
22. Syversen S.W., Gaarder P.I., Goll G.L., Odegard S., Haavardsholm E.A., Mowinckel P., et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008, 67:212-217. [Epub 2007/05/29].
23. Saevarsdottir S., Forslind K., Albertsson K., Rezaei H., Engström A., Geborek P., et al. Development of a matrix risk model to predict rapid radiographic progression in early rheumatoid arthritis. Results from a randomized trial population. Arthritis Rheum 2011, 63:S983.
24. Fautrel B., Granger B., Combe B., Saraux A., Guillemin F., Le Loet X. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort. Arthritis Res Ther 2012, 14:R249. [Epub 2012/11/21].
25. Durnez A., Vanderschueren G., Lateur L., Westhovens R., Verschueren P. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort. Ann Rheum Dis 2011, 70:634-637.
26. Lillegraven S., Paynter N., Prince F.H., Shadick N.A., Haavardsholm E.A., Frits M.L., et al. The performance of matrix-based risk models for rapid radiographic progression in BRASS, a cohort of patients with established rheumatoid arthritis. Arthritis Care Res 2012, 65(4):526-533. [Epub 2012/10/10].
27. Fautrel B, Granger B, Combe B, Le Loet X. Performance of rapid radiographic progression prediction matrices in the early rheumatoid arthritis patients of the espoir cohort [abstract]. Eular 2012; [2012 june 6-9; Berlin 2012].
28. Verschueren P., Esselens G., Westhovens R. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:59-64.
29. Verschueren P., Esselens G., Westhovens R. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Scand J Rheumatol 2009, 38:166-172.
30. Esselens G., Westhovens R., Verschueren P. Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis. Musculoskeletal Care 2009, 7:1-16. [Epub 2008/07/12].
31. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999, 26:743-745. [Epub 1999/03/25].
32. Sharp J.T., Bluhm G.B., Brook A., Brower A.C., Corbett M., Decker J.L., et al. Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum 1985, 28:16-24. [Epub 1985/01/01].
33. Sharp J.T., Wolfe F., Mitchell D.M., Bloch D.A. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 1991, 34:660-668. [Epub 1991/06/01].
34. Bombardier C., Li X., Gregersen P., van der Heijde D., Chen M. A risk model for the prediction of radiographic progression: results from SONORA study. Arthritis Rheum 2009, 61:S276.